Home / Ingredients / Moringa (Moringa oleifera)

Moringa (Moringa oleifera)

Evidence reviewed: 2026-10-02

Evidence posture

Human cardiometabolic evidence is inconsistent and very low certainty overall; broad glucose, lipid, weight, or blood-pressure claims are not established.

What the evidence supports

A 2025 GRADE-assessed meta-analysis of randomized trials found no significant effect on most cardiometabolic outcomes and rated certainty very low. A modest diastolic blood-pressure signal was not robust in sensitivity analysis. Small individual trials likewise show inconsistent, non-dose-dependent effects.

Studied context

Trials use different Moringa oleifera leaf powders or preparations, doses, populations, and durations. Many studies are small and heterogeneous.

Safety context

The small and heterogeneous randomized-trial evidence base does not provide strong long-term safety certainty for concentrated or high-dose preparations. Safety conclusions should remain preparation-specific.

Product directness

V-ITAREN lists moringa leaf without a disclosed amount or preparation details. The current low-certainty human evidence cannot establish finished-product cardiometabolic efficacy.

Products that list this ingredient/category

Primary and authoritative sources

Review-level evidence highlights

Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment (Systematic review and meta-analysis of randomized controlled trials with GRADE assessment; PMID 41305552)

Population/scope: Nine randomized controlled trials; 341 participants in intervention groups and 308 controls

Evidence scope: Anthropometrics, lipid profile, glycemic indices, and blood pressure

Finding: No significant effect was found for most outcomes; a modest diastolic blood-pressure reduction was observed but was not robust in sensitivity analysis.

Limitations: Risk of bias, substantial heterogeneity, indirectness, and methodological limitations reduced certainty to very low for all evaluated outcomes.

Directness: Relevant human evidence ยท verified 2026-10-02

Important: Ingredient-level evidence is not proof that a finished product has the same effect. Dose, form, population, duration, and formulation must match.

For informational purposes only; not individualized medical advice.